Spreadsheet: 0ab88498-5d7c-4283-9fe2-45e3485ea807
Sheet: Sheet1

File #2, Over expression, down regulated genes | File#2 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4
Category | Function Annotation | P-value | Molecules | # Molecules
Cellular Development | differentiation of lymphatic system cells | 1.81e-05 | EGR1, FOS, LMO1, NFE2 | 4
Cellular Development | differentiation of blood cells | 2.67e-05 | EGR1, FOS, LMO1, NFE2 | 4
Cellular Development | differentiation of lymphocytes | 0.000185 | EGR1, FOS, LMO1 | 3
Cellular Development | differentiation of mononuclear leukocytes | 0.000273 | EGR1, FOS, LMO1 | 3
Cellular Development | differentiation of leukocytes | 0.000487 | EGR1, FOS, LMO1 | 3
Cellular Development | differentiation of B lymphocytes | 0.000846 | EGR1, FOS | 2
Cellular Development | differentiation of cells | 0.00188 | EGR1, FOS, LMO1, NFE2 | 4
Cellular Development | differentiation of T lymphocytes | 0.00307 | EGR1, LMO1 | 2
Cellular Development | differentiation of B-1 lymphocytes | 0.00323 | EGR1 | 1
Cellular Development | differentiation of megakaryocytes | 0.0106 | NFE2 | 1
Cellular Development | maturation of lymphatic system cells | 4.28e-05 | EGR1, FOS, NFE2 | 3
Cellular Development | maturation of cells | 0.000265 | EGR1, FOS, NFE2 | 3
Cellular Development | maturation of dendritic cells | 0.000412 | EGR1, FOS | 2
Cellular Development | arrest in maturation of megakaryocytes | 0.000462 | NFE2 | 1
Cellular Development | maturation of antigen presenting cells | 0.000499 | EGR1, FOS | 2
Cellular Development | arrest in maturation of lymphatic system cells | 0.000924 | NFE2 | 1
Cellular Development | arrest in maturation of hematopoietic progenitor cells | 0.00139 | NFE2 | 1
Cellular Development | arrest in maturation of blood cells | 0.00185 | NFE2 | 1
Cellular Development | arrest in maturation of cells | 0.00231 | NFE2 | 1
Cellular Development | maturation of plasmacytoid dendritic cells | 0.00323 | EGR1 | 1
Cellular Development | maturation of megakaryocytes | 0.00599 | NFE2 | 1
Cellular Development | maturation of hematopoietic progenitor cells | 0.0106 | NFE2 | 1
Cellular Development | maturation of hematopoietic cells | 0.011 | NFE2 | 1
Cellular Development | maturation of bone marrow cells | 0.0156 | NFE2 | 1
Cellular Development | development of macrophages | 6.69e-05 | EGR1, FOS | 2
Cellular Development | development of phagocytes | 7.69e-05 | EGR1, FOS | 2
Cellular Development | development of antigen presenting cells | 0.000191 | EGR1, FOS | 2
Cellular Development | development of lymphocytes | 0.00451 | EGR1, FOS | 2
Cellular Development | development of mononuclear leukocytes | 0.00478 | EGR1, FOS | 2
Cellular Development | development of leukocytes | 0.00534 | EGR1, FOS | 2
Cellular Development | development of lymphatic system cells | 0.00785 | EGR1, FOS | 2
Cellular Development | development of blood cells | 0.0083 | EGR1, FOS | 2
Cellular Development | development of osteoclasts | 0.0147 | FOS | 1
Cellular Development | developmental process of blood cells | 0.000125 | EGR1, FOS, LMO1, NFE2 | 4
Cellular Development | developmental process of lymphocytes | 0.00079 | EGR1, FOS, LMO1 | 3
Cellular Development | developmental process of dendritic cells | 0.00101 | EGR1, FOS | 2
Cellular Development | developmental process of mononuclear leukocytes | 0.00102 | EGR1, FOS, LMO1 | 3
Cellular Development | developmental process of leukocytes | 0.00154 | EGR1, FOS, LMO1 | 3
Cellular Development | developmental process of macrophages | 0.00171 | EGR1, FOS | 2
Cellular Development | developmental process of hematopoietic progenitor cells | 0.00173 | EGR1, NFE2 | 2
Cellular Development | developmental process of phagocytes | 0.00201 | EGR1, FOS | 2
Cellular Development | developmental process of hematopoietic cells | 0.00211 | EGR1, NFE2 | 2
Cellular Development | arrest in developmental process of bone marrow cells | 0.00231 | NFE2 | 1
Cellular Development | arrest in developmental process of hematopoietic progenitor cells | 0.00231 | NFE2 | 1
Cellular Development | developmental process of leukocyte cell lines | 0.0025 | EGR1, FOS | 2
Cellular Development | developmental process of B lymphocytes | 0.0027 | EGR1, FOS | 2
Cellular Development | developmental process of antigen presenting cells | 0.00337 | EGR1, FOS | 2
Cellular Development | developmental process of B-1 lymphocytes | 0.00783 | EGR1 | 1
Cellular Development | developmental process of bone marrow-derived macrophages | 0.00783 | FOS | 1
Cellular Development | developmental process of plasmacytoid dendritic cells | 0.00783 | EGR1 | 1
Cellular Development | developmental process of T lymphocytes | 0.00908 | EGR1, LMO1 | 2
Cellular Development | developmental process of hepatocytes | 0.0124 | FOS | 1
Cellular Development | arrest in developmental process of blood cells | 0.0161 | NFE2 | 1
Cellular Development | conversion of mesenchymal cells | 0.000924 | FOS | 1
Cellular Development | conversion of epithelial cells | 0.00415 | FOS | 1
Cellular Development | arrest in growth of kidney cell lines | 0.00185 | FOS | 1
Cellular Development | growth of hepatocytes | 0.00783 | FOS | 1
Cellular Development | growth of liver cells | 0.00875 | FOS | 1
Cellular Development | arrest in growth of fibroblast cell lines | 0.0101 | FOS | 1
Cellular Development | growth of keratinocytes | 0.0133 | FOS | 1
Cellular Development | growth of epidermal cells | 0.0156 | FOS | 1
Cellular Development | growth of dermal cells | 0.0161 | FOS | 1
Cellular Development | osteoclastogenesis of bone marrow-derived macrophages | 0.00323 | FOS | 1
Cellular Development | osteoclastogenesis of macrophages | 0.00966 | FOS | 1
Cellular Development | osteoclastogenesis of lymphatic system cells | 0.0124 | FOS | 1
Cellular Development | osteoclastogenesis of osteoclasts | 0.0133 | FOS | 1
Cellular Development | osteoclastogenesis of connective tissue cells | 0.0138 | FOS | 1
Cellular Development | lymphopoiesis of B lymphocytes | 0.00645 | FOS | 1
Cellular Development | lymphopoiesis of lymphocytes | 0.00691 | FOS | 1
Cellular Development | lymphopoiesis of leukocytes | 0.00737 | FOS | 1
Cellular Development | lymphopoiesis of blood cells | 0.00783 | FOS | 1
Cellular Development | hematopoiesis of leukocytes | 0.0101 | FOS | 1
Hematological System Development and Function | differentiation of blood cells | 2.67e-05 | EGR1, FOS, LMO1, NFE2 | 4
Hematological System Development and Function | differentiation of lymphocytes | 0.000185 | EGR1, FOS, LMO1 | 3
Hematological System Development and Function | differentiation of mononuclear leukocytes | 0.000273 | EGR1, FOS, LMO1 | 3
Hematological System Development and Function | differentiation of leukocytes | 0.000487 | EGR1, FOS, LMO1 | 3
Hematological System Development and Function | differentiation of B lymphocytes | 0.000846 | EGR1, FOS | 2
Hematological System Development and Function | differentiation of T lymphocytes | 0.00307 | EGR1, LMO1 | 2
Hematological System Development and Function | differentiation of B-1 lymphocytes | 0.00323 | EGR1 | 1
Hematological System Development and Function | differentiation of megakaryocytes | 0.0106 | NFE2 | 1
Hematological System Development and Function | development of macrophages | 6.69e-05 | EGR1, FOS | 2
Hematological System Development and Function | development of phagocytes | 7.69e-05 | EGR1, FOS | 2
Hematological System Development and Function | development of lymphocytes | 0.00451 | EGR1, FOS | 2
Hematological System Development and Function | development of mononuclear leukocytes | 0.00478 | EGR1, FOS | 2
Hematological System Development and Function | development of leukocytes | 0.00534 | EGR1, FOS | 2
Hematological System Development and Function | development of blood cells | 0.0083 | EGR1, FOS | 2
Hematological System Development and Function | hematological process | 0.000109 | EGR1, FOS, LMO1, NFE2 | 4
Hematological System Development and Function | hematological process of leukocytes | 0.0129 | FOS | 1
Hematological System Development and Function | arrest in maturation of megakaryocytes | 0.000462 | NFE2 | 1
Hematological System Development and Function | arrest in maturation of hematopoietic progenitor cells | 0.00139 | NFE2 | 1
Hematological System Development and Function | maturation of megakaryocytes | 0.00599 | NFE2 | 1
Hematological System Development and Function | maturation of hematopoietic progenitor cells | 0.0106 | NFE2 | 1
Hematological System Development and Function | maturation of hematopoietic cells | 0.011 | NFE2 | 1
Hematological System Development and Function | metabolism of thymocytes | 0.000924 | EGR1 | 1
Hematological System Development and Function | metabolism of T lymphocytes | 0.00139 | EGR1 | 1
Hematological System Development and Function | hematopoiesis | 0.00146 | EGR1, FOS, LMO1 | 3
Hematological System Development and Function | hematopoiesis of leukocytes | 0.0101 | FOS | 1
Hematological System Development and Function | accumulation of blood cells | 0.00201 | EGR1, KRT19 | 2
Hematological System Development and Function | accumulation of eosinophils | 0.00829 | EGR1 | 1
Hematological System Development and Function | production of blood platelets | 0.00277 | NFE2 | 1
Hematological System Development and Function | production of blood cells | 0.0161 | NFE2 | 1
Hematological System Development and Function | osteoclastogenesis of bone marrow-derived macrophages | 0.00323 | FOS | 1
Hematological System Development and Function | osteoclastogenesis of macrophages | 0.00966 | FOS | 1
Hematological System Development and Function | formation of megakaryocytes | 0.00369 | NFE2 | 1
Hematological System Development and Function | formation of hematopoietic progenitor cells | 0.00645 | NFE2 | 1
Hematological System Development and Function | formation of hematopoietic cells | 0.00691 | NFE2 | 1
Hematological System Development and Function | formation of macrophages | 0.00829 | EGR1 | 1
Hematological System Development and Function | proliferation of megakaryocytes | 0.00461 | NFE2 | 1
Hematological System Development and Function | hemostasis | 0.00507 | NFE2 | 1
Hematological System Development and Function | morphology of blood platelets | 0.00507 | NFE2 | 1
Hematological System Development and Function | morphology of red blood cells | 0.00645 | NFE2 | 1
Hematological System Development and Function | survival of red blood cells | 0.00507 | NFE2 | 1
Hematological System Development and Function | lymphopoiesis of B lymphocytes | 0.00645 | FOS | 1
Hematological System Development and Function | lymphopoiesis of lymphocytes | 0.00691 | FOS | 1
Hematological System Development and Function | lymphopoiesis of leukocytes | 0.00737 | FOS | 1
Hematological System Development and Function | lymphopoiesis of blood cells | 0.00783 | FOS | 1
Hematological System Development and Function | lymphopoiesis of eukaryotic cells | 0.00966 | FOS | 1
Hematological System Development and Function | lymphopoiesis of lymphatic system cells | 0.00966 | FOS | 1
Cancer | morphology of tumor cell lines | 3e-05 | EGR1, FOS, NFE2 | 3
Cancer | morphology of germ cell tumor cell lines | 0.000924 | EGR1 | 1
Cancer | morphology of leukemia cell lines | 0.00369 | NFE2 | 1
Cancer | morphology of breast cancer cell lines | 0.0115 | FOS | 1
Cancer | hematologic cancer of mice | 0.000233 | EGR1, LMO1 | 2
Cancer | hematologic cancer of mammalia | 0.000252 | EGR1, LMO1 | 2
Cancer | hematologic cancer | 0.00951 | EGR1, LMO1 | 2
Cancer | leukemia of mice | 0.000233 | EGR1, LMO1 | 2
Cancer | leukemia of mammalia | 0.000252 | EGR1, LMO1 | 2
Cancer | leukemia | 0.0077 | EGR1, LMO1 | 2
Cancer | induction of osteosarcoma | 0.000462 | FOS | 1
Cancer | induction of sarcoma | 0.00139 | FOS | 1
Cancer | induction of malignant tumor | 0.00323 | FOS | 1
Cancer | induction of primary tumor | 0.00461 | FOS | 1
Cancer | induction of tumor | 0.011 | FOS | 1
Cancer | tumorigenesis of sebaceous adenoma | 0.000462 | FOS | 1
Cancer | tumorigenesis of malignant tumor | 0.0007 | EGR1, FOS | 2
Cancer | tumorigenesis of mice | 0.000812 | EGR1, LMO1 | 2
Cancer | tumorigenesis of primary tumor | 0.000846 | EGR1, FOS | 2
Cancer | tumorigenesis of rodents | 0.000863 | EGR1, LMO1 | 2
Cancer | tumorigenesis of tumor cell lines | 0.000863 | EGR1, FOS | 2
Cancer | tumorigenesis of sebaceous gland tumor | 0.000924 | FOS | 1
Cancer | tumorigenesis of mammalia | 0.00114 | EGR1, LMO1 | 2
Cancer | tumorigenesis of cell lines | 0.00164 | EGR1, FOS | 2
Cancer | tumorigenesis of leukemia cell lines | 0.00231 | EGR1 | 1
Cancer | tumorigenesis of cervical cancer cell lines | 0.00277 | FOS | 1
Cancer | tumorigenesis of tumor | 0.0035 | EGR1, FOS | 2
Cancer | tumorigenesis of skin tumor | 0.00415 | FOS | 1
Cancer | tumorigenesis of squamous cell tumor | 0.00461 | FOS | 1
Cancer | tumorigenesis of eukaryotic cells | 0.00518 | EGR1, FOS | 2
Cancer | tumorigenesis of cells | 0.00581 | EGR1, FOS | 2
Cancer | growth of leukemia cell lines | 0.000567 | EGR1, LMO1 | 2
Cancer | arrest in growth of melanoma cells | 0.00139 | EGR1 | 1
Cancer | arrest in growth of cancer cells | 0.00507 | EGR1 | 1
Cancer | arrest in growth of tumor cells | 0.00553 | EGR1 | 1
Cancer | growth of fibrosarcoma cell lines | 0.00553 | EGR1 | 1
Cancer | growth of melanoma cells | 0.00783 | EGR1 | 1
Cancer | cancer of mice | 0.000581 | EGR1, LMO1 | 2
Cancer | cancer of rodents | 0.00061 | EGR1, LMO1 | 2
Cancer | cancer of mammalia | 0.000747 | EGR1, LMO1 | 2
Cancer | cancer | 0.0126 | EGR1, FOS, [NAME], LMO1 | 4
Cancer | disease process of malignant tumor | 0.000715 | EGR1, FOS | 2
Cancer | disease process of primary tumor | 0.000863 | EGR1, FOS | 2
Cancer | disease process of tumor cell lines | 0.00152 | EGR1, FOS | 2
Cancer | disease process of tumor | 0.0036 | EGR1, FOS | 2
Cancer | disease process of cervical cancer cell lines | 0.00599 | FOS | 1
Cancer | disease process of leukemia cell lines | 0.00875 | EGR1 | 1
Cancer | neoplasia of mice | 0.000779 | EGR1, LMO1 | 2
Cancer | neoplasia of rodents | 0.000812 | EGR1, LMO1 | 2
Cancer | [NAME] of mammalia | 0.00108 | EGR1, LMO1 | 2
Cancer | neoplasia | 0.015 | EGR1, FOS, [NAME], LMO1 | 4
Cancer | arrest in G0/G1 phase transition of melanoma cells | 0.000924 | EGR1 | 1
Cancer | arrest in G0/G1 phase transition of cancer cells | 0.00139 | EGR1 | 1
Cancer | arrest in G0/G1 phase transition of tumor cells | 0.00139 | EGR1 | 1
Cancer | formation of lung cancer cell lines | 0.000924 | EGR1 | 1
Cancer | formation of osteosarcoma | 0.00139 | FOS | 1
Cancer | formation of bone tumor | 0.00323 | FOS | 1
Cancer | formation of sarcoma | 0.00645 | FOS | 1
Cancer | formation of tumor cell lines | 0.0133 | EGR1 | 1
Cancer | sebaceous adenoma | 0.000924 | FOS | 1
Cancer | arrest in interphase of melanoma cells | 0.00139 | EGR1 | 1
Cancer | arrest in interphase of cancer cells | 0.00645 | EGR1 | 1
Cancer | arrest in interphase of tumor cells | 0.00737 | EGR1 | 1
Cancer | interphase of cancer cells | 0.0106 | EGR1 | 1
Cancer | interphase of tumor cells | 0.012 | EGR1 | 1
Cancer | sebaceous gland tumor | 0.00139 | FOS | 1
Cancer | apoptosis of prostate cancer cell lines | 0.0015 | EGR1, FOS | 2
Cancer | T-cell acute lymphoblastic leukemia of mice | 0.00185 | LMO1 | 1
Cancer | T-cell acute lymphoblastic leukemia | 0.00599 | LMO1 | 1
Cancer | hyperplasia of sebaceous glands | 0.00185 | FOS | 1
Cancer | hyperplasia of exocrine gland | 0.00875 | FOS | 1
Cancer | hyperplasia of secretory structure | 0.0124 | FOS | 1
Cancer | cell death of prostate cancer cell lines | 0.00188 | EGR1, FOS | 2
Cancer | attachment of brain cancer cell lines | 0.00231 | EGR1 | 1
Cancer | attachment of tumor cell lines | 0.0147 | EGR1 | 1
Cancer | cell division process of melanoma cells | 0.00231 | EGR1 | 1
Cancer | arrest in cell division process of cancer cells | 0.00966 | EGR1 | 1
Cancer | arrest in cell division process of tumor cells | 0.0115 | EGR1 | 1
Cancer | cell division process of prostate cancer cell lines | 0.0165 | EGR1 | 1
Cancer | proliferation of tumor cell lines | 0.00274 | EGR1, FOS, NFE2 | 3
Cancer | acute lymphoblastic leukemia of mice | 0.00277 | LMO1 | 1
Cancer | developmental process of leukemia cell lines | 0.00317 | EGR1, LMO1 | 2
Cancer | arrest in developmental process of cancer cells | 0.00599 | EGR1 | 1
Cancer | arrest in developmental process of tumor cells | 0.00645 | EGR1 | 1
Cancer | developmental process of fibrosarcoma cell lines | 0.00691 | EGR1 | 1
Cancer | developmental process of tumor cell lines | 0.00696 | EGR1, FOS, LMO1 | 3
Cancer | developmental process of lymphoma | 0.00875 | EGR1 | 1
Cancer | colony formation of tumor cell lines | 0.0033 | EGR1, FOS | 2
Cancer | colony formation of leukemia cell lines | 0.00461 | EGR1 | 1
Cancer | colony formation of carcinoma cell lines | 0.00829 | EGR1 | 1
Cancer | colony formation of prostate cancer cell lines | 0.00829 | EGR1 | 1
Cancer | development of T-cell non-hodgkin lymphoma | 0.00369 | EGR1 | 1
Cancer | development of non-hodgkin lymphoma | 0.00507 | EGR1 | 1
Cancer | development of lymphoma | 0.00783 | EGR1 | 1
Cancer | T-cell leukemia of mammalia | 0.00415 | LMO1 | 1
Cancer | T-cell leukemia of mice | 0.00415 | LMO1 | 1
Cancer | T-cell leukemia of organism | 0.00461 | LMO1 | 1
Cancer | T-cell leukemia | 0.0147 | LMO1 | 1
Cancer | acute lymphocytic leukemia of mice | 0.00461 | LMO1 | 1
Cancer | acute lymphocytic leukemia of mammalia | 0.00507 | LMO1 | 1
Cancer | tumor | 0.00569 | EGR1, FOS, [NAME], LMO1 | 4
Cancer | acute T-cell leukemia | 0.00691 | LMO1 | 1
Cancer | arrest in cell stage of cancer cells | 0.00691 | EGR1 | 1
Cancer | arrest in cell stage of tumor cells | 0.00875 | EGR1 | 1
Cancer | cell stage of cancer cells | 0.0115 | EGR1 | 1
Cancer | cell stage of tumor cells | 0.0138 | EGR1 | 1
Cancer | cell cycle progression of prostate cancer cell lines | 0.00737 | EGR1 | 1
Cancer | myeloproliferative syndrome of mammalia | 0.00737 | EGR1 | 1
Cancer | myeloproliferative syndrome of mice | 0.00737 | EGR1 | 1
Cancer | differentiation of tumor cell lines | 0.00913 | EGR1, FOS | 2
Cancer | differentiation of germ cell tumor cell lines | 0.0142 | EGR1 | 1
Cancer | lymphocytic leukemia of mice | 0.00921 | LMO1 | 1
Cancer | lymphocytic leukemia of mammalia | 0.00966 | LMO1 | 1
Cancer | incidence of tumor | 0.012 | EGR1 | 1
Cancer | myeloid leukemia of mammalia | 0.0129 | EGR1 | 1
Cancer | myeloid leukemia of mice | 0.0129 | EGR1 | 1
Cancer | osteosarcoma | 0.0138 | FOS | 1
Cancer | carcinoma | 0.0147 | EGR1, FOS, [NAME] | 3
Cancer | size of tumor | 0.0152 | LMO1 | 1
Cell Morphology | morphology of tumor cell lines | 3e-05 | EGR1, FOS, NFE2 | 3
Cell Morphology | morphology of cell lines | 0.000133 | EGR1, FOS, NFE2 | 3
Cell Morphology | morphology of anterior pituitary cells | 0.000462 | EGR1 | 1
Cell Morphology | morphology of somatotrophs | 0.000462 | EGR1 | 1
Cell Morphology | morphology of eukaryotic cells | 0.000702 | EGR1, FOS, NFE2 | 3
Cell Morphology | morphology of germ cell tumor cell lines | 0.000924 | EGR1 | 1
Cell Morphology | morphology of cells | 0.000969 | EGR1, FOS, NFE2 | 3
Cell Morphology | morphology of brain cells | 0.00231 | EGR1 | 1
Cell Morphology | morphology of neuroendocrine cells | 0.00231 | EGR1 | 1
Cell Morphology | morphology of leukemia cell lines | 0.00369 | NFE2 | 1
Cell Morphology | morphology of endocrine cells | 0.00415 | EGR1 | 1
Cell Morphology | morphology of blood platelets | 0.00507 | NFE2 | 1
Cell Morphology | morphology of central nervous system cells | 0.00645 | EGR1 | 1
Cell Morphology | morphology of red blood cells | 0.00645 | NFE2 | 1
Cell Morphology | morphology of breast cancer cell lines | 0.0115 | FOS | 1
Cell Morphology | depolarization of epithelial cells | 0.000462 | FOS | 1
Cell Morphology | volume of acinar gland cells | 0.000462 | AQP5 | 1
Cell Morphology | volume of pancreatic cells | 0.000924 | AQP5 | 1
Cell Morphology | volume of endocrine cells | 0.00139 | AQP5 | 1
Cell Morphology | volume of eukaryotic cells | 0.0124 | AQP5 | 1
Cell Morphology | volume of cells | 0.0152 | AQP5 | 1
Cell Morphology | conversion of mesenchymal cells | 0.000924 | FOS | 1
Cell Morphology | conversion of embryonic cells | 0.00139 | FOS | 1
Cell Morphology | conversion of epithelial cells | 0.00415 | FOS | 1
Cell Morphology | conversion of eukaryotic cells | 0.0142 | FOS | 1
Cell Morphology | deformation of red blood cells | 0.00139 | NFE2 | 1
Cell Morphology | deformation of cells | 0.00185 | NFE2 | 1
Cell Morphology | modification of embryonic cells | 0.00231 | FOS | 1
Cell Morphology | ruffling of plasma membrane | 0.011 | FOS | 1
Cell Morphology | shape change of plasma membrane | 0.0129 | FOS | 1
[NAME] | activation of Gal4p binding site | 3.37e-05 | FOS, NFE2 | 2
[NAME] | activation of [NAME] binding site | 0.00139 | EGR1 | 1
[NAME] | activation of Fin1 binding site | 0.00231 | FOS | 1
[NAME] | activation of NF-E2 binding site | 0.00231 | NFE2 | 1
[NAME] | activation of Usf1 binding site | 0.00231 | FOS | 1
[NAME] | activation of Egr-1 binding site | 0.00323 | EGR1 | 1
[NAME] | activation of DR5 retinoic acid response element | 0.00369 | FOS | 1
[NAME] | activation of ATF binding site | 0.00415 | FOS | 1
[NAME] | activation of CarG box | 0.00415 | FOS | 1
[NAME] | activation of AP1/CRE element | 0.00461 | FOS | 1
[NAME] | activation of gene | 0.00572 | FOS, NFE2 | 2
[NAME] | activation of Ets element | 0.00921 | FOS | 1
[NAME] | activation of TGF beta response element | 0.00921 | FOS | 1
[NAME] | activation of NFAT response element | 0.0101 | EGR1 | 1
[NAME] | activation of estrogen response element | 0.0152 | FOS | 1
[NAME] | repression of CarG box | 0.000462 | FOS | 1
[NAME] | repression of dyad symmetry element | 0.000924 | FOS | 1
[NAME] | repression of serum response element | 0.00185 | FOS | 1
[NAME] | transactivation of [NAME] binding site | 0.000924 | EGR1 | 1
[NAME] | transactivation of Egr-1 binding site | 0.000924 | EGR1 | 1
[NAME] | transactivation of NF-E2 binding site | 0.000924 | NFE2 | 1
[NAME] | transactivation of [NAME] binding site | 0.000924 | EGR1 | 1
[NAME] | transactivation | 0.0021 | EGR1, FOS, NFE2 | 3
[NAME] | transactivation of NFAT response element | 0.00507 | EGR1 | 1
[NAME] | transactivation of Gal4p binding site | 0.00599 | NFE2 | 1
[NAME] | transactivation of cAMP response element | 0.00737 | FOS | 1
[NAME] | transactivation of NFkB binding site | 0.00875 | FOS | 1
[NAME] | transactivation of protein binding site | 0.00875 | EGR1 | 1
[NAME] | transactivation of AP1 consensus site | 0.00921 | FOS | 1
[NAME] | transactivation of estrogen response element | 0.00966 | FOS | 1
[NAME] | transcription of Egr binding site | 0.00139 | EGR1 | 1
[NAME] | transcription of C/ebp alpha binding element | 0.00185 | EGR1 | 1
[NAME] | transcription of hypoxia response element | 0.00323 | EGR1 | 1
[NAME] | transcription of AP1 response element | 0.00691 | FOS | 1
[NAME] | transcription of AP1 consensus site | 0.012 | FOS | 1
[NAME] | transcription of DNA | 0.0125 | EGR1, FOS, NFE2 | 3
[NAME] | transcription of synthetic promoter | 0.013 | EGR1, FOS | 2
[NAME] | transrepression of gene | 0.00139 | FOS | 1
[NAME] | transrepression | 0.00415 | FOS | 1
[NAME] | inhibition of serum response element | 0.00231 | FOS | 1
[NAME] | binding of Ets element | 0.00323 | FOS | 1
[NAME] | binding of Egr-1 binding site | 0.00369 | EGR1 | 1
[NAME] | binding of Sp1 binding site | 0.0115 | EGR1 | 1
[NAME] | expression of hypoxia response element | 0.00415 | EGR1 | 1
[NAME] | expression of antioxidant response element | 0.00507 | FOS | 1
[NAME] | expression of AP1 response element | 0.00966 | FOS | 1
[NAME] | expression of DNA endogenous promoter | 0.011 | EGR1 | 1
[NAME] | expression of DNA | 0.0134 | EGR1, FOS, NFE2 | 3
[NAME] | expression of AP1 consensus site | 0.0142 | FOS | 1
[NAME] | expression of synthetic promoter | 0.0156 | EGR1, FOS | 2
[NAME] | stabilization of reporter mRNA | 0.00507 | FOS | 1
[NAME] | induction of gene | 0.00691 | FOS | 1
[NAME] | bending of DNA | 0.00829 | FOS | 1
[NAME] | methylation of DNA | 0.0129 | FOS | 1
Immune and Lymphatic System Development and Function | development of macrophages | 6.69e-05 | EGR1, FOS | 2
Immune and Lymphatic System Development and Function | development of lymphocytes | 0.00451 | EGR1, FOS | 2
Immune and Lymphatic System Development and Function | formation of bone marrow cells | 7.18e-05 | EGR1, NFE2 | 2
Immune and Lymphatic System Development and Function | formation of proplatelets | 0.00277 | NFE2 | 1
Immune and Lymphatic System Development and Function | formation of megakaryocytes | 0.00369 | NFE2 | 1
Immune and Lymphatic System Development and Function | formation of macrophages | 0.00829 | EGR1 | 1
Immune and Lymphatic System Development and Function | differentiation of lymphocytes | 0.000185 | EGR1, FOS, LMO1 | 3
Immune and Lymphatic System Development and Function | differentiation of mononuclear leukocytes | 0.000273 | EGR1, FOS, LMO1 | 3
Immune and Lymphatic System Development and Function | differentiation of leukocytes | 0.000487 | EGR1, FOS, LMO1 | 3
Immune and Lymphatic System Development and Function | differentiation of B lymphocytes | 0.000846 | EGR1, FOS | 2
Immune and Lymphatic System Development and Function | differentiation of T lymphocytes | 0.00307 | EGR1, LMO1 | 2
Immune and Lymphatic System Development and Function | differentiation of B-1 lymphocytes | 0.00323 | EGR1 | 1
Immune and Lymphatic System Development and Function | differentiation of megakaryocytes | 0.0106 | NFE2 | 1
Immune and Lymphatic System Development and Function | mitosis of Th1 lymphocytes | 0.000462 | FOS | 1
Immune and Lymphatic System Development and Function | mitosis of T lymphocytes | 0.00231 | FOS | 1
Immune and Lymphatic System Development and Function | mitosis of lymphocytes | 0.00277 | FOS | 1
Immune and Lymphatic System Development and Function | metabolism of thymocytes | 0.000924 | EGR1 | 1
Immune and Lymphatic System Development and Function | metabolism of T lymphocytes | 0.00139 | EGR1 | 1
Immune and Lymphatic System Development and Function | osteoclastogenesis of bone marrow-derived macrophages | 0.00323 | FOS | 1
Immune and Lymphatic System Development and Function | osteoclastogenesis of macrophages | 0.00966 | FOS | 1
Immune and Lymphatic System Development and Function | proliferation of megakaryocytes | 0.00461 | NFE2 | 1
Immune and Lymphatic System Development and Function | lymphopoiesis of B lymphocytes | 0.00645 | FOS | 1
Immune and Lymphatic System Development and Function | lymphopoiesis of lymphocytes | 0.00691 | FOS | 1
Immune and Lymphatic System Development and Function | lymphopoiesis of leukocytes | 0.00737 | FOS | 1
Immune and Lymphatic System Development and Function | lymphopoiesis of blood cells | 0.00783 | FOS | 1
Immune and Lymphatic System Development and Function | lymphopoiesis of eukaryotic cells | 0.00966 | FOS | 1
Immune and Lymphatic System Development and Function | lymphopoiesis of lymphatic system cells | 0.00966 | FOS | 1
Immune and Lymphatic System Development and Function | accumulation of eosinophils | 0.00829 | EGR1 | 1
Immune and Lymphatic System Development and Function | immunological process of B lymphocytes | 0.0129 | FOS | 1
Cellular Growth and Proliferation | formation of bone marrow cells | 7.18e-05 | EGR1, NFE2 | 2
Cellular Growth and Proliferation | formation of lymphatic system cells | 0.000281 | EGR1, NFE2 | 2
Cellular Growth and Proliferation | formation of blood cells | 0.000291 | EGR1, NFE2 | 2
Cellular Growth and Proliferation | formation of lung cancer cell lines | 0.000924 | EGR1 | 1
Cellular Growth and Proliferation | formation of megakaryocytes | 0.00369 | NFE2 | 1
Cellular Growth and Proliferation | formation of osteoclast-like cells | 0.00599 | EGR1 | 1
Cellular Growth and Proliferation | formation of eukaryotic cells | 0.00602 | EGR1, NFE2 | 2
Cellular Growth and Proliferation | formation of hematopoietic progenitor cells | 0.00645 | NFE2 | 1
Cellular Growth and Proliferation | formation of cells | 0.00656 | EGR1, NFE2 | 2
Cellular Growth and Proliferation | formation of hematopoietic cells | 0.00691 | NFE2 | 1
Cellular Growth and Proliferation | formation of macrophages | 0.00829 | EGR1 | 1
Cellular Growth and Proliferation | formation of antigen presenting cells | 0.00966 | EGR1 | 1
Cellular Growth and Proliferation | formation of tumor cell lines | 0.0133 | EGR1 | 1
Cellular Growth and Proliferation | growth of leukemia cell lines | 0.000567 | EGR1, LMO1 | 2
Cellular Growth and Proliferation | arrest in growth of melanoma cells | 0.00139 | EGR1 | 1
Cellular Growth and Proliferation | arrest in growth of kidney cell lines | 0.00185 | FOS | 1
Cellular Growth and Proliferation | arrest in growth of eukaryotic cells | 0.00208 | EGR1, FOS | 2
Cellular Growth and Proliferation | arrest in growth of cells | 0.00261 | EGR1, FOS | 2
Cellular Growth and Proliferation | arrest in growth of cancer cells | 0.00507 | EGR1 | 1
Cellular Growth and Proliferation | arrest in growth of tumor cells | 0.00553 | EGR1 | 1
Cellular Growth and Proliferation | growth of fibrosarcoma cell lines | 0.00553 | EGR1 | 1
Cellular Growth and Proliferation | growth of cell lines | 0.00727 | EGR1, FOS, LMO1 | 3
Cellular Growth and Proliferation | growth of hepatocytes | 0.00783 | FOS | 1
Cellular Growth and Proliferation | growth of melanoma cells | 0.00783 | EGR1 | 1
Cellular Growth and Proliferation | growth of parenchymal cells | 0.00829 | FOS | 1
Cellular Growth and Proliferation | growth of liver cells | 0.00875 | FOS | 1
Cellular Growth and Proliferation | arrest in growth of fibroblast cell lines | 0.0101 | FOS | 1
Cellular Growth and Proliferation | growth of keratinocytes | 0.0133 | FOS | 1
Cellular Growth and Proliferation | growth of eukaryotic cells | 0.0146 | EGR1, FOS, LMO1 | 3
Cellular Growth and Proliferation | growth of epidermal cells | 0.0156 | FOS | 1
Cellular Growth and Proliferation | growth of dermal cells | 0.0161 | FOS | 1
Cellular Growth and Proliferation | colony formation | 0.000624 | EGR1, FOS, NFE2 | 3
Cellular Growth and Proliferation | colony formation of cells | 0.000624 | EGR1, FOS, NFE2 | 3
Cellular Growth and Proliferation | colony formation of tumor cell lines | 0.0033 | EGR1, FOS | 2
Cellular Growth and Proliferation | colony formation of leukemia cell lines | 0.00461 | EGR1 | 1
Cellular Growth and Proliferation | colony formation of cell lines | 0.00679 | EGR1, FOS | 2
Cellular Growth and Proliferation | colony formation of carcinoma cell lines | 0.00829 | EGR1 | 1
Cellular Growth and Proliferation | colony formation of prostate cancer cell lines | 0.00829 | EGR1 | 1
Cellular Growth and Proliferation | colony formation of eukaryotic cells | 0.0121 | EGR1, FOS | 2
Cellular Growth and Proliferation | proliferation of tumor cell lines | 0.00274 | EGR1, FOS, NFE2 | 3
Cellular Growth and Proliferation | proliferation of megakaryocytes | 0.00461 | NFE2 | 1
Cellular Growth and Proliferation | proliferation of cell lines | 0.00804 | EGR1, FOS, NFE2 | 3
Cellular Growth and Proliferation | proliferation of cells | 0.0115 | EGR1, FOS, LMO1, NFE2 | 4
Cellular Growth and Proliferation | production of blood platelets | 0.00277 | NFE2 | 1
Cellular Growth and Proliferation | production of blood cells | 0.0161 | NFE2 | 1
Cell Cycle | arrest in G0/G1 phase transition of eukaryotic cells | 0.000182 | EGR1, FOS | 2
Cell Cycle | G0/G1 phase transition of eukaryotic cells | 0.000271 | EGR1, FOS | 2
Cell Cycle | arrest in G0/G1 phase transition of hematopoietic progenitor cells | 0.000462 | FOS | 1
Cell Cycle | arrest in G0/G1 phase transition of melanoma cells | 0.000924 | EGR1 | 1
Cell Cycle | arrest in G0/G1 phase transition of blood cells | 0.00139 | FOS | 1
Cell Cycle | arrest in G0/G1 phase transition of cancer cells | 0.00139 | EGR1 | 1
Cell Cycle | arrest in G0/G1 phase transition of tumor cells | 0.00139 | EGR1 | 1
Cell Cycle | G0/G1 phase transition of blood cells | 0.00231 | FOS | 1
Cell Cycle | arrest in G0 phase of eukaryotic cells | 0.000199 | EGR1, FOS | 2
Cell Cycle | G0 phase of eukaryotic cells | 0.000322 | EGR1, FOS | 2
Cell Cycle | G0 phase of blood cells | 0.00277 | FOS | 1
Cell Cycle | metaphase/anaphase transition of eukaryotic cells | 0.000462 | EGR1 | 1
Cell Cycle | metaphase/anaphase transition of liver cells | 0.000462 | EGR1 | 1
Cell Cycle | metaphase/anaphase transition | 0.00277 | EGR1 | 1
Cell Cycle | mitosis of Th1 lymphocytes | 0.000462 | FOS | 1
Cell Cycle | mitosis of T lymphocytes | 0.00231 | FOS | 1
Cell Cycle | mitosis of lymphocytes | 0.00277 | FOS | 1
Cell Cycle | mitosis of lymphatic system cells | 0.00323 | FOS | 1
Cell Cycle | mitosis of blood cells | 0.00737 | FOS | 1
Cell Cycle | cell division process of Th1 lymphocytes | 0.000924 | FOS | 1
Cell Cycle | arrest in cell division process of hematopoietic cells | 0.00231 | FOS | 1
Cell Cycle | cell division process of melanoma cells | 0.00231 | EGR1 | 1
Cell Cycle | entry into cell division process of cells | 0.0034 | EGR1, FOS | 2
Cell Cycle | arrest in cell division process of cancer cells | 0.00966 | EGR1 | 1
Cell Cycle | cell division process of hematopoietic progenitor cells | 0.011 | FOS | 1
Cell Cycle | arrest in cell division process of tumor cells | 0.0115 | EGR1 | 1
Cell Cycle | cell division process of liver cells | 0.0115 | EGR1 | 1
Cell Cycle | cell division process of hematopoietic cells | 0.012 | FOS | 1
Cell Cycle | entry into cell division process of fibroblast cell lines | 0.0138 | FOS | 1
Cell Cycle | arrest in cell division process of eukaryotic cells | 0.0144 | EGR1, FOS | 2
Cell Cycle | cell division process of prostate cancer cell lines | 0.0165 | EGR1 | 1
Cell Cycle | cell stage of helper inducer T lymphocytes | 0.000924 | FOS | 1
Cell Cycle | entry into cell stage of cells | 0.00255 | EGR1, FOS | 2
Cell Cycle | cell stage of hematopoietic progenitor cells | 0.00553 | FOS | 1
Cell Cycle | arrest in cell stage of cancer cells | 0.00691 | EGR1 | 1
Cell Cycle | cell stage of liver cells | 0.00691 | EGR1 | 1
Cell Cycle | arrest in cell stage of eukaryotic cells | 0.00866 | EGR1, FOS | 2
Cell Cycle | arrest in cell stage of tumor cells | 0.00875 | EGR1 | 1
Cell Cycle | cell stage of T lymphocytes | 0.0101 | FOS | 1
Cell Cycle | arrest in cell stage of blood cells | 0.0115 | FOS | 1
Cell Cycle | cell stage of cancer cells | 0.0115 | EGR1 | 1
Cell Cycle | arrest in cell stage | 0.012 | EGR1, FOS | 2
Cell Cycle | arrest in cell stage of cells | 0.012 | EGR1, FOS | 2
Cell Cycle | entry into cell stage of fibroblast cell lines | 0.0133 | FOS | 1
Cell Cycle | cell stage of tumor cells | 0.0138 | EGR1 | 1
Cell Cycle | arrest in interphase of hematopoietic progenitor cells | 0.00139 | FOS | 1
Cell Cycle | arrest in interphase of melanoma cells | 0.00139 | EGR1 | 1
Cell Cycle | interphase of hematopoietic progenitor cells | 0.00277 | FOS | 1
Cell Cycle | arrest in interphase of cancer cells | 0.00645 | EGR1 | 1
Cell Cycle | arrest in interphase of eukaryotic cells | 0.00726 | EGR1, FOS | 2
Cell Cycle | arrest in interphase of tumor cells | 0.00737 | EGR1 | 1
Cell Cycle | interphase of cancer cells | 0.0106 | EGR1 | 1
Cell Cycle | arrest in interphase of blood cells | 0.011 | FOS | 1
Cell Cycle | entry into interphase of fibroblast cell lines | 0.012 | FOS | 1
Cell Cycle | interphase of tumor cells | 0.012 | EGR1 | 1
Cell Cycle | cell cycle progression of prostate cancer cell lines | 0.00737 | EGR1 | 1
Cell Cycle | entry into S phase of fibroblast cell lines | 0.0115 | FOS | 1